US HB6513 | 2021-2022 | 117th Congress
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on January 28 2022 - 25% progression, died in committee
Action: 2022-01-31 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 28 2022 - 25% progression, died in committee
Action: 2022-01-31 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to exempt from regulation as devices non-invasive diagnostic devices, and for other purposes.
Title
Medical Innovation Acceleration Act of 2022
Sponsors
Rep. Andy Biggs [R-AZ] |
History
Date | Chamber | Action |
---|---|---|
2022-01-31 | House | Referred to the Subcommittee on Health. |
2022-01-28 | House | Referred to the House Committee on Energy and Commerce. |
2022-01-28 | House | Introduced in House |
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/117th-congress/house-bill/6513/all-info |
Text | https://www.congress.gov/117/bills/hr6513/BILLS-117hr6513ih.pdf |